Key Takeaways for Astera Labs Stock as of July 2026
- Analysts rate Astera Labs stock 11 buys / 7 outperforms / 8 holds / 0 sells with a mean target of $272, implying around 44% downside from the current price of $483.
- TIKR’s mid-case model values Astera Labs at around $1,176 by December 2030, implying around 144% total return, or roughly 22% annualized.
- Astera Labs stock is undervalued at current levels, with revenue expected to reach around $410 million in Q3 2026, up around 78% year-over-year, as consensus models have not fully incorporated the Scorpio X ramp that management says will make Scorpio the company’s largest product line by year-end.
- Q1 2026 revenue jumped 93% year-over-year to $308 million, beating the $292 million consensus estimate, driven by initial Scorpio X volume shipments and PCIe Gen 6 adoption now exceeding one-third of total revenue.
Astera Labs Posts 93% Revenue Growth as Scorpio X Shipments Begin, Redefining Its Product Mix
Astera Labs (ALAB) designs intelligent connectivity semiconductors for AI infrastructure, and its Q1 2026 results showed the company’s transition from an I/O component supplier into a full-stack AI fabric provider is already generating revenue.
Q1 revenue hit $308 million, up 93% year-over-year and 14% quarter-over-quarter, clearing the $292 million consensus by around $16 million.
That growth came from two converging forces: the continued ramp of PCIe Gen 6 across the Aries signal conditioning and Scorpio P-Series fabric switch portfolios, and the first initial production volumes from the Scorpio X-Series, the company’s scale-up AI fabric switch designed for large XPU clustering.
The more important signal is what PCIe Gen 6 now represents inside the income statement. CEO Jitendra Mohan confirmed on the Q1 earnings call that PCIe Gen 6 revenue across fabric and signal conditioning already contributes more than one-third of total company revenue, with millions of Gen 6 ports shipped to date.
Beneath the headline number, the Scorpio franchise is inflecting fast. CFO Desmond Lynch addressed the trajectory directly on the call: “We would expect to see that Scorpio will become our largest product line by the end of the year, which is strong performance for a product line that was only 15% of total company revenue last year.” The 320-lane Scorpio X, designed to replace multiple legacy switches in a single hop for large-scale XPU racks, begins full volume production in the second half of 2026.
That shift matters competitively because lane count correlates directly to ASP, and management has confirmed silicon dollar content per accelerator now exceeds $1,000, up from under $100 at IPO.
On the cost side, non-GAAP gross margin widened 70 basis points sequentially to 76.4%, even as R&D spending absorbed a full quarter of the aiXscale Photonics acquisition and a partial quarter from the new Israel Design Center. Non-GAAP operating margin held at 36.2%.
Q2 guidance calls for revenue of $355 million to $365 million, up 15% to 18% sequentially, with non-GAAP EPS of $0.68 to $0.70. Management flagged a 200-basis-point non-cash gross margin headwind from a newly executed customer warrant agreement, pulling Q2 non-GAAP gross margin guidance to approximately 73%.
Analysts Remain Cautiously Positioned on Astera Labs Stock Despite an Aggressive Growth Ramp
Twenty-six analysts cover Astera Labs stock, with 11 buys, 7 outperforms, 8 holds, and zero sells. The mean price target of around $272 sits roughly 44% below the current price of $483, a gap that shows how far the stock has outrun Wall Street’s models since the Q1 beat.
Even the highest target on the Street, at $460, sits below where ALAB trades today.
Wall Street Expects Astera Labs Stock Revenue to Sustain Above-70% Growth Through Late 2026
Revenue of $308 million in Q1 2026 represented 93% year-over-year growth, the highest rate in the data set, with PCIe Gen 6 and early Scorpio X volumes driving the outperformance against consensus.
Consensus now models Q2 2026 revenue at around $360 million, up around 88% year-over-year, stepping to around $410 million in Q3 and around $470 million in Q4.
Looking further out, the Street models revenue reaching around $510 million by Q1 2027 and around $550 million by Q2 2027, representing year-over-year growth rates of around 67% and 51% respectively as the comparables become more demanding.
The Street looks like it has not yet fully priced the Scorpio X ramp into its models. Management confirmed 10-plus active customer engagements for scale-up connectivity and guided explicitly for X-Series volume production to accelerate in the second half of 2026, a dynamic that implies consensus Q3 and Q4 revenue estimates carry meaningful upside risk if the flagship 320-lane product ramps on schedule.
ALAB Stock Is Growing Revenue at Nearly 3x the Rate of Its Closest Semiconductor Peers
Astera Labs stock is outpacing its two largest merchant AI connectivity peers by a wide margin. In Q1 2026, ALAB posted 93% year-over-year revenue growth against Marvell’s (MRVL) 35% and Broadcom’s (AVGO) 48%.
That gap holds through the forward estimates. Consensus models ALAB at around 88% revenue growth in Q2 2026, stepping to around 78% in Q3, while Marvell sits at around 45% for the same period. Broadcom’s Q3 estimate of around 94% is inflated by VMware consolidation revenue, not organic AI semiconductor growth.
Into 2027, ALAB’s comparables steepen and the spread compresses, but does not close. With Scorpio X expanding from one lead hyperscaler to multiple accounts, the consensus trajectory may still be too low.
TIKR’s $1,176 Target on ALAB Stock Implies 144% Upside if the Scorpio X Ramp Executes
TIKR’s mid-case model values Astera Labs at around $1,176 by December 2030, implying around 144% total return from the current price of $483, or roughly 22% annualized over the next 4.5 years.
That annualized return sits well above typical semiconductor sector expectations, pricing in a scenario where Astera sustains above-market revenue growth as Scorpio X penetrates a scale-up fabric opportunity that management sizes at more than $10 billion.
The path to that target is already partially de-risked. Initial Scorpio X volume shipments started in Q1 2026, the 320-lane flagship entered production in Q2, and management confirmed both P-Series and X-Series ramps continue through the second half of the year, with PCIe Gen 6 already generating more than one-third of total revenue from a portfolio that was essentially zero on Gen 6 a year ago.
Should You Invest in Astera Labs, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Astera Labs, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Astera Labs, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze ALAB stock on TIKR for Free →
